IL110460A - Bite-naphthalimides, their preparation and pharmaceutical preparations containing them - Google Patents

Bite-naphthalimides, their preparation and pharmaceutical preparations containing them

Info

Publication number
IL110460A
IL110460A IL11046094A IL11046094A IL110460A IL 110460 A IL110460 A IL 110460A IL 11046094 A IL11046094 A IL 11046094A IL 11046094 A IL11046094 A IL 11046094A IL 110460 A IL110460 A IL 110460A
Authority
IL
Israel
Prior art keywords
bis
compound
formula
alkyl
ethyl
Prior art date
Application number
IL11046094A
Other languages
English (en)
Hebrew (he)
Other versions
IL110460A0 (en
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of IL110460A0 publication Critical patent/IL110460A0/xx
Publication of IL110460A publication Critical patent/IL110460A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/06—Ring systems of three rings
    • C07D221/14—Aza-phenalenes, e.g. 1,8-naphthalimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
IL11046094A 1993-08-18 1994-07-26 Bite-naphthalimides, their preparation and pharmaceutical preparations containing them IL110460A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10894993A 1993-08-18 1993-08-18

Publications (2)

Publication Number Publication Date
IL110460A0 IL110460A0 (en) 1994-10-21
IL110460A true IL110460A (en) 2001-01-11

Family

ID=22324990

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11046094A IL110460A (en) 1993-08-18 1994-07-26 Bite-naphthalimides, their preparation and pharmaceutical preparations containing them

Country Status (28)

Country Link
US (3) US5616589A (no)
EP (1) EP0714387B1 (no)
JP (1) JPH09501662A (no)
KR (1) KR960703863A (no)
CN (1) CN1039414C (no)
AT (1) ATE166647T1 (no)
AU (1) AU677696B2 (no)
BR (2) BR9407257A (no)
CA (1) CA2169059A1 (no)
CZ (1) CZ34296A3 (no)
DE (1) DE69410614T2 (no)
DK (1) DK0714387T3 (no)
ES (1) ES2116612T3 (no)
FI (1) FI960658A (no)
HR (1) HRP940458B1 (no)
HU (1) HU219232B (no)
IL (1) IL110460A (no)
NO (1) NO305554B1 (no)
NZ (1) NZ271374A (no)
PH (1) PH31395A (no)
PL (1) PL313078A1 (no)
RU (1) RU2138484C1 (no)
SG (1) SG64906A1 (no)
SI (1) SI9420053A (no)
TW (1) TW408112B (no)
UA (1) UA42733C2 (no)
WO (1) WO1995005365A1 (no)
ZA (1) ZA946196B (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5703089A (en) * 1994-04-28 1997-12-30 Knoll Aktiengesellschaft Dihydrodibenzisoquinolinediones
IL129475A0 (en) * 1996-10-21 2000-02-29 Allelix Biopharma Neurotrophin antagonist compositions
US6531454B1 (en) 1999-03-16 2003-03-11 The Regents Of The University Of California Glycosylated polyamines and methods of use therefor
US6420344B1 (en) 1999-03-16 2002-07-16 The Regents Of The University Of California Glycosylated polyamines
US6468990B1 (en) 1999-05-17 2002-10-22 Queen's University At Kingston Method of inhibiting binding of nerve growth factor to p75 NTR receptor
US6492380B1 (en) 1999-05-17 2002-12-10 Queen's University At Kingston Method of inhibiting neurotrophin-receptor binding
ATE250603T1 (de) * 2000-03-07 2003-10-15 Us Gov Health & Human Serv 1,8-naphthalimid imidazo(4,5,1-de)acridone mit antitumorwirkung
EP2047866B1 (en) 2003-11-05 2011-04-20 PhotoBioMed Corporation Bonding tissues and cross-linking proteins with naphthalimide compounds
MXPA06012660A (es) * 2004-05-05 2007-03-23 Unibioscreen Sa Derivados de naftalimida para el tratamiento de cancer.
US7947839B2 (en) 2004-12-01 2011-05-24 Genentech, Inc. Heterocyclic-substituted bis-1,8 naphthalimide compounds, antibody drug conjugates, and methods of use
WO2006060533A2 (en) 2004-12-01 2006-06-08 Genentech, Inc. Conjugates of 1, 8-bis-naphthalimides with an antibody
US20070134243A1 (en) * 2004-12-01 2007-06-14 Gazzard Lewis J Antibody drug conjugates and methods
CN101305002A (zh) 2005-09-15 2008-11-12 佩因赛普托药物公司 调节神经营养蛋白介导的活性的方法
WO2009089537A2 (en) 2008-01-11 2009-07-16 Northwestern University Anti-cancer compounds

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3535496A1 (de) * 1985-10-04 1987-04-16 Bayer Ag Verfahren zur fluoreszenzloeschung und neue kationische naphthalin-peri-dicarbonsaeureimid-derivate
DE3707651A1 (de) * 1987-03-10 1988-09-22 Knoll Ag Bis-naphthalimide, ihre herstellung und verwendung
US5086052A (en) * 1987-07-17 1992-02-04 Abbott Laboratories Substituted 1,4,5,6-tetrahydro-2H-pyridazin-3-one and -3-thione compounds having lipoxygenase inhibitory activity
US5086059A (en) * 1990-06-07 1992-02-04 Du Pont Merck Pharmaceutical Company Bis-naphthalimides as anticancer agents
US5206249A (en) * 1991-03-27 1993-04-27 Du Pont Merck Pharmaceutical Company Bis-naphthalimides containing amino-acid derived linkers as anticancer agents
AU3241593A (en) * 1991-12-11 1993-07-19 Du Pont Merck Pharmaceutical Company, The Highly water soluble bis-naphthalimides useful as anticancer agents
DE4232739A1 (de) * 1992-09-30 1994-03-31 Knoll Ag Neue asymmetrisch substituierte bis-Naphthalimide

Also Published As

Publication number Publication date
RU2138484C1 (ru) 1999-09-27
NO960632D0 (no) 1996-02-16
NZ271374A (en) 1997-05-26
CN1132506A (zh) 1996-10-02
AU677696B2 (en) 1997-05-01
ZA946196B (en) 1996-02-19
WO1995005365A1 (en) 1995-02-23
TW408112B (en) 2000-10-11
UA42733C2 (uk) 2001-11-15
KR960703863A (ko) 1996-08-31
PL313078A1 (en) 1996-05-27
NO305554B1 (no) 1999-06-21
SI9420053A (en) 1996-08-31
AU7498494A (en) 1995-03-14
US5616589A (en) 1997-04-01
US5981753A (en) 1999-11-09
HU9600360D0 (en) 1996-04-29
DE69410614D1 (de) 1998-07-02
DE69410614T2 (de) 1998-09-24
DK0714387T3 (da) 1998-10-12
ES2116612T3 (es) 1998-07-16
BR1100143A (pt) 2000-03-14
ATE166647T1 (de) 1998-06-15
BR9407257A (pt) 1996-09-24
CA2169059A1 (en) 1995-02-23
JPH09501662A (ja) 1997-02-18
CN1039414C (zh) 1998-08-05
CZ34296A3 (en) 1996-08-14
SG64906A1 (en) 1999-05-25
HU219232B (en) 2001-03-28
EP0714387B1 (en) 1998-05-27
US5789418A (en) 1998-08-04
NO960632L (no) 1996-02-16
HRP940458A2 (en) 1997-06-30
IL110460A0 (en) 1994-10-21
HUT73529A (en) 1996-08-28
PH31395A (en) 1998-10-29
FI960658A0 (fi) 1996-02-14
HRP940458B1 (en) 2000-02-29
FI960658A (fi) 1996-02-14
EP0714387A1 (en) 1996-06-05

Similar Documents

Publication Publication Date Title
US5376664A (en) Unsymmetrical mono-3-nitro bis-naphthalimides as anticancer agents
EP0714387B1 (en) New bis-naphthalimides for the treatment of cancer
NZ242126A (en) Bis[5-nitro-1h-benz[de]isoquinoline-1,3(2h)-dione] derivatives; medicaments; preparation of intermediates
KR100190732B1 (ko) 신규한 축합 인단 유도체 및 그의 약학적으로 허용가능한염
GB1603228A (en) Indole derivatives a process for preparing them and pharmaceutical compositions containing them
CA2084643A1 (en) Bis-naphthalimides anticancer agents
US5703089A (en) Dihydrodibenzisoquinolinediones
AU2001240054B2 (en) 1,8-Naphthalimide Imidazo[4,5,1-de]acridones with Anti-Tumor Activity
AU2001240054A1 (en) 1,8-Naphthalimide Imidazo[4,5,1-de]acridones with Anti-Tumor Activity
TW397826B (en) High purity 6,9-bis[(2-aminoethyl)amino]benzno[G]-isoquinoline-5,10-dione dimaleate and method of synthesis
CA2085598C (en) 1,2-dihydro-3h-dibenzisoquinoline-1,3-dione anticancer agents
WO1995029895A1 (en) Dihydrodibenzo(de,h)isoquinolines derivatives and their use as anti-cancer agents
EP0785191B1 (en) Fused indan derivatives and salts thereof
JP2001011078A (ja) ７−オキソ−２，３，７，１４−テトラヒドロ−１Ｈ−ベンゾ〔ｂ〕ピラノ〔３，２−ｈ〕アクリジンカルボキシラートの新しい化合物、これらの製造方法及びこれらを含む医薬組成物
WO1994003432A1 (en) Polyhydroxylated naphthyl 2-carboxylate, and quinolyl and isoquinolyl 3-carboxylate derivatives as protein tyrosine kinase inhibitors
WO1994018171A1 (en) Unsymmetrical bis-imides as anticancer agents
WO1991005770A1 (en) Potential anticancer agents derived from acridine
WO1994005641A1 (en) 4-SUBSTITUTED 6,9,-BIS (SUBSTITUTED-AMINO) BENZO [g] ISOQUINOLINE-5,10,DIONES
ITMI971850A1 (it) Derivati di pirazolo-acridine aventi attivita' antitumorale
ITMI971851A1 (it) Derivati di ammino-acridine carbossiammidi aventi attivita' antitumorale

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees